Genmab — Januar 2018
-
https://www.businesswire.com/news/home/20180102005149/en/Syros-Announces-Clinical-Supply-Agreement-Janssen-Evaluate Syros Announces Clinical Supply Agreement with Janssen
-
tak E L. SY-1425 bliver så det andet cd38-fremmende stof, der afprøves sammen med dara i klinikken. Dog ikke i MM. Det andet stof, ATRA i MM, har vi ikke hørt meget om. Plesner har tidligere udtrykt skepsis https://www.youtube.com/watch?v=RUpfj1PskPM
-
it is a relatively cheap trial for Janssen , only providing Dara in exchange for the info. I would assume they see at least some merit in trying , and this way they dont have to do it themselves. Lets have a few more of these and hope that some have success. (i am starting the year as an optimist, not sure how long that will last
) -
No,
and cant immediately find it on their site, maybe in 1 of the articles on the bottom here https://www.syros.com/programs/sy-1425 -
@EL around 40,000 shares
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind